Secure Traffic Sign Recognition: An Attention-Enabled Universal Image Inpainting Mechanism against Light Patch Attacks

Traffic sign recognition systems play a crucial role in assisting drivers to make informed decisions while driving. However, due to the heavy reliance on deep learning technologies, particularly for future connected and autonomous driving, these systems are susceptible to adversarial attacks that pose significant safety risks to both personal and public transportation. Notably, researchers recently identified a new attack vector to deceive sign recognition systems: projecting well-designed adversarial light patches onto traffic signs. In comparison with traditional adversarial stickers or graffiti, these emerging light patches exhibit heightened aggression due to their ease of implementation and outstanding stealthiness. To effectively counter this security threat, we propose a universal image inpainting mechanism, namely, SafeSign. It relies on attention-enabled multi-view image fusion to repair traffic signs contaminated by adversarial light patches, thereby ensuring the accurate sign recognition. Here, we initially explore the fundamental impact of malicious light patches on the local and global feature spaces of authentic traffic signs. Then, we design a binary mask-based U-Net image generation pipeline outputting diverse contaminated sign patterns, to provide our image inpainting model with needed training data. Following this, we develop an attention mechanism-enabled neural network to jointly utilize the complementary information from multi-view images to repair contaminated signs. Finally, extensive experiments are conducted to evaluate SafeSign's effectiveness in resisting potential light patch-based attacks, bringing an average accuracy improvement of 54.8% in three widely-used sign recognition models

Personalised Drug Identifier for Cancer Treatment with Transformers using Auxiliary Information

Cancer remains a global challenge due to its growing clinical and economic burden. Its uniquely personal manifestation, which makes treatment difficult, has fuelled the quest for personalized treatment strategies. Thus, genomic profiling is increasingly becoming part of clinical diagnostic panels. Effective use of such panels requires accurate drug response prediction (DRP) models, which are challenging to build due to limited labelled patient data. Previous methods to address this problem have used various forms of transfer learning. However, they do not explicitly model the variable length sequential structure of the list of mutations in such diagnostic panels. Further, they do not utilize auxiliary information (like patient survival) for model training. We address these limitations through a novel transformer based method, which surpasses the performance of state-of-the-art DRP models on benchmark data. We also present the design of a treatment recommendation system (TRS), which is currently deployed at the National University Hospital, Singapore and is being evaluated in a clinical trial.